uncomplicated urinary tract infections

Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):25-30

In May 2016 the U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone drugs for systemic use and advised to restrict their prescribing for the treatment of acute sinusitis, uncomplicated urinary tract infections …

Choice of Antimicrobial Agents in Uncomplicated Urinary Tract Infections: How to Make Decision Worthy of Solomon?

Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(1):18-25

Antimicrobials for the treatment of uncomplicated urinary tract infections (UTI) include different drug classes: fluoroquinolones, cephalosporins, beta-lactam/betalactamase inhibitor combinations, aminoglycosides, carbapenems, nitrofurans, …